Tamma PD - Search Results

1

Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children.

Chiotos K, Tamma PD, Flett KB, Karandikar MV, Nemati K, Bilker WB, Zaoutis T, Han JH. Chiotos K, et al. Among authors: tamma pd. Open Forum Infect Dis. 2018 Sep 10;5(10):ofy222. doi: 10.1093/ofid/ofy222. eCollection 2018 Oct. Open Forum Infect Dis. 2018. PMID: 30338267 Free PMC article.

2

Pediatric antimicrobial susceptibility trends across the United States.

Tamma PD, Robinson GL, Gerber JS, Newland JG, DeLisle CM, Zaoutis TE, Milstone AM. Tamma PD, et al. Infect Control Hosp Epidemiol. 2013 Dec;34(12):1244-51. doi: 10.1086/673974. Epub 2013 Oct 28. Infect Control Hosp Epidemiol. 2013. PMID: 24225608

3

Treatment of multidrug-resistant Gram-negative infections in children.

Hsu AJ, Tamma PD. Hsu AJ, et al. Among authors: tamma pd. Clin Infect Dis. 2014 May;58(10):1439-48. doi: 10.1093/cid/ciu069. Epub 2014 Feb 5. Clin Infect Dis. 2014. PMID: 24501388 Review.

4

Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.

Tamma PD, Hsu AJ. Tamma PD, et al. Curr Opin Infect Dis. 2014 Dec;27(6):517-27. doi: 10.1097/QCO.0000000000000115. Curr Opin Infect Dis. 2014. PMID: 25313503 Review.

5

Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.

Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, Avdic E, Cosgrove SE; Antibacterial Resistance Leadership Group. Tamma PD, et al. Clin Infect Dis. 2015 May 1;60(9):1319-25. doi: 10.1093/cid/civ003. Epub 2015 Jan 13. Clin Infect Dis. 2015. PMID: 25586681 Free PMC article.

6

Carbapenem-Resistant Enterobacteriaceae Infections in Children.

Chiotos K, Han JH, Tamma PD. Chiotos K, et al. Among authors: tamma pd. Curr Infect Dis Rep. 2016 Jan;18(1):2. doi: 10.1007/s11908-015-0510-9. Curr Infect Dis Rep. 2016. PMID: 26711126 Free PMC article.

7

A Clinical Decision Tree to Predict Whether a Bacteremic Patient Is Infected With an Extended-Spectrum β-Lactamase-Producing Organism.

Goodman KE, Lessler J, Cosgrove SE, Harris AD, Lautenbach E, Han JH, Milstone AM, Massey CJ, Tamma PD; Antibacterial Resistance Leadership Group. Goodman KE, et al. Among authors: tamma pd. Clin Infect Dis. 2016 Oct 1;63(7):896-903. doi: 10.1093/cid/ciw425. Epub 2016 Jun 28. Clin Infect Dis. 2016. PMID: 27358356 Free PMC article.

8

Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bacteremia.

Wang R, Cosgrove SE, Tschudin-Sutter S, Han JH, Turnbull AE, Hsu AJ, Avdic E, Carroll KC, Tamma PD. Wang R, et al. Among authors: tamma pd. Open Forum Infect Dis. 2016 Jun 20;3(3):ofw132. doi: 10.1093/ofid/ofw132. eCollection 2016 Sep. Open Forum Infect Dis. 2016. PMID: 27419191 Free PMC article.

9

Determining the Optimal Carbapenem MIC That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae.

Tamma PD, Huang Y, Opene BN, Simner PJ. Tamma PD, et al. Antimicrob Agents Chemother. 2016 Sep 23;60(10):6425-9. doi: 10.1128/AAC.00838-16. Print 2016 Oct. Antimicrob Agents Chemother. 2016. PMID: 27503655 Free PMC article.

10

Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.

Tamma PD, Goodman KE, Harris AD, Tekle T, Roberts A, Taiwo A, Simner PJ. Tamma PD, et al. Clin Infect Dis. 2017 Feb 1;64(3):257-264. doi: 10.1093/cid/ciw741. Epub 2016 Nov 9. Clin Infect Dis. 2017. PMID: 28013264 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page